Management of Metastatic Renal Clear Cell Cancer Rapid Recommendation Update
Dr. Eric Singer highlights the recent rapid recommendation update from ASCO on the management of metastatic renal cell cancer (ccRCC), based on the review of evidence from the phase III COSMIC 313 tri...
10 Loka 20237min
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated GEP-NETs Guideline
Dr. Jaydira Del Rivero and Dr. Kimberly Perez discuss the latest ASCO guideline featuring evidence-based recommendations on systemic therapy for well-differentiated grade 1 to grade 3 metastatic gastr...
29 Syys 202318min
Systemic Therapy for Melanoma Guideline Update
Dr. Michael Atkins and Dr. Vernon Sondak highlight the latest updates to the systemic therapy for melanoma recommendations in this newest guideline. The discussion covers neoadjuvant and adjuvant ther...
6 Syys 202316min
Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults with Cancer: SIO-ASCO Guideline
Dr. Julia Rowland shares the newest evidence-based recommendations from SIO and ASCO on integrative therapies for managing anxiety and depression symptoms in adults with cancer. Listen in to hear reco...
15 Elo 202314min
Management of Stage III NSCLC Rapid Recommendation Update
Dr. Navneet Singh joins us again, this time to discuss the rapid recommendation update for stage III non-small cell lung cancer, incorporating updated data presented at the 2023 ASCO Annual Meeting. H...
20 Heinä 20238min
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy Guideline Update
Dr. Supriya Mohile , Dr. William Dale, and Dr. Heidi Klepin discuss the updated guideline on the practical assessment and management of age-associated vulnerabilities in older patients undergoing syst...
17 Heinä 202323min
Cancer Cachexia Rapid Recommendation Update
Dr. Charles Loprinzi shares the latest update to the management of cancer cachexia guideline. Dr. Loprinzi discusses the evidence that prompted the rapid update to the guideline and reviews the new ev...
12 Heinä 20238min
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.2
Dr. Navneet Singh highlights the latest evidence-based recommendation updates from the ASCO living guideline on stage IV non-small cell lung cancer with driver alterations. This update focuses on new ...
11 Heinä 20237min
